Aurobindo Pharma partners with a global firm to develop respiratory drugs, investing up to $90M.

Aurobindo Pharma, an Indian drugmaker, has teamed up with a major global pharmaceutical company to develop and sell respiratory drugs. Aurobindo will pay up to $90 million for development costs, and both companies will share marketing rights. The unnamed partner will handle manufacturing. This collaboration aims to speed up product launches and enhance Aurobindo's drug offerings.

November 23, 2024
3 Articles

Further Reading